Breast Neoplasm
Conditions
Keywords
Physical Activity, Exercise, Exercise Therapy, Breast Neoplasms, Medical costs, Healthcare Costs
Brief summary
Adapted physical activity (APA) was recognized as a non-drug therapy by the French Health Authority (HAS) in 2011. Very few studies have examined the efficiency of APA programs during the active phase of treatment in cancer patients. The investigators assumed that non-drug therapy such as APA could improve the quality of life and reduces health costs. The main objective of this study is to assess the efficiency of a standardized APA program, as compared to conventional management including simple recommendations for the practice of physical activity in women in phase active breast cancer treatment.
Detailed description
Scientific rationale: The incidence of breast cancer in women is on the rise again over the period 2010-2018. The overall cost of cancer treatment is 16.8 billion euros, including 3.6 billion for drugs alone. The treatments are more and more prolonged, the proportion of anticancer drugs continues to increase with 10% of the amount reimbursed for drugs delivered in pharmacies in 2017. Adapted physical activity (APA) was recognized as a non-drug therapy by the HAS in 2011. It reduces certain side effects of treatments, as well as certain symptoms linked to the catabolic activity of the disease such as: fat gain, loss of muscle mass, physical deconditioning, fatigue or pain. For breast cancer, a meta-analysis showed that APA following adjuvant therapy may have a beneficial effect on quality of life. The APA shows in particular for breast cancer, a reduction in all-cause mortality as well as specific mortality and a reduction in recurrence.The prescription of APA has been allowed since the 2016 health law but there is no coverage by the French national health insurance fund (CNAM) despite the benefits shown. APA is only accessible in a few centers in France that have chosen to offer it to patients, thus creating social inequalities in health. Very few studies have examined the efficiency of APA programs during the active phase of treatment. They related to cohorts of 60 to 165 patients and uses different methods. The investigators decided to set up a study that can measure the efficiency of the standardized APA programs offered to patients diagnosed with breast cancer, assuming that non-drug therapy such as APA would improve the quality of life while reducing health costs. Description of the procedures: The intervention consists of an initial consultation appointment with a medical check-up and physical tests, then inclusion in the standardized APA program for 6 months. The control group will be offered the same initial consultation appointment with medical check-up and physical tests and will receive recommendations for physical practice as well as a calendar of activities to be practiced independently for 6 months. Inclusion in the APA program will be offered one year after inclusion. Follow-up: The data will be collected at T0, T + 3 months, T + 6 months, T + 9 months and T + 12 months in both arms. There will be 1 year of data analysis.
Interventions
OTHERAPA Program
Patients treated and monitored for their breast cancer following the 6-month APA program.
OTHERRecommendations for physical activity
Patients treated and monitored for their breast cancer who have received recommendations for physical activity as well as a 6-month activity schedule. To facilitate patient acceptance and participation in this study, patients who will be randomized to the control group will be offered to follow the APA program after one year of inclusion
Sponsors
University Hospital, Toulouse
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* women with breast cancer * any type of breast cancer, all grades, all stages * during treatment: surgery +/- chemotherapy +/- radiotherapy +/- hormone therapy
Exclusion criteria
* World Health Organization (WHO) 4 * Unstable angina * Uncontrolled Atrial fibrillation * Uncontrolled high blood pressure * Recent myocardial infarction or myocarditis or pericarditis or thromboembolic disease (less than 3 weeks) * Aortic stenosis or valve disease to operate * Cardiac or respiratory failure, with dyspnea at rest * Symptomatic anemia, thrombocytopenia * Lytic or painful bone metastases, Severe osteoporosis * Severe infectious syndrome, * Surgery in the last 3 weeks * Extreme fatigue, sharp pain, dizziness, disturbance of consciousness, severe undernutrition * Contraindication to the practice of an adapted physical activity programme * Currently involved or exclusion period of a interventional study or adapted Physical Activity program * Patient with protective measures (guardianship, curators, and deprivation of liberty). * Pregnancy or breastfeeding * Patient with severe functional limitations
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Comparison of physical activity programmes | 12 months | Evaluation of the differential cost-utility ratio (cost / QALY), according to the perspective of the community over a 12-month period, of an adapted physical activity program (APA) in comparison to conventional care, including simple recommendations for physical activity for patients with breast cancer during the active phase of treatment. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Clinical efficacy | 12 months | Progression-free survival measured for non-metastatic (relapse-free survival) and metastatic (progression-free survival) patients |
| Efficacy on specific functions | 12 months | BR23-QLQ-C30 questionnaire. Breast Cancer Specific Quality of Life Questionnaire (BR23-QLQ-C30) is a 52-item questionnaire. The choices range from 1 not at all to 4 very much. |
| Society impact (interview) | 12 months | Zarit-Burden Interview |
| Society impact | 12 months | Number of hours of informal help for basic and instrumental activities of daily life |
| Breast cancer-specific quality of life | 12 months | Breast Cancer Specific Quality of Life Questionnaire (QLQ) (BR23-QLQ-C30) is a 52-item questionnaire. The choices range from 1 not at all to 4 very much. |
| Programme compliance rate | 12 months | Traced by the reservation system for adapted physical activity (APA) sessions |
| Rate of hospital care | 12 months | Direct medical costs |
| Rate of difference in the effect of the programme | 12 months | Socioeconomic determinants (changes in income, socio-professional category, level of education and family environment) |
| Rate of financial benefit of the programme | 5 years | Annual and 5-year net financial benefit of the systematic implementation of an adapted physical activity (APA) program |
| Patient satisfaction | 12 months | Patient satisfaction questionnaire (EORTC-IN-PATSAT32) is a 32-item questionnaire. The choices range from 1 bad to 4 excellent. |
Countries
France
Contacts
Primary ContactMarie-Eve Rougé-Bugat, MD
Outcome results
None listed